Australian AI infrastructure startup Firmus Technologies has finalised a US$10 billion debt financing facility led by funds managed by Blackstone Tactical Opportunities and Blackstone Credit & Insurance, with support from technology investor Coatue Management. The transaction, announced on 9 February 2026, ranks among the largest private debt financings in Australian history. The capital will fund Project Southgate — a national rollout of Firmus's AI Factory platform built on NVIDIA's DSX reference architecture — developed in partnership with CDC Data Centres and Nvidia. The initiative is designed to reach a capacity of up to 1.6 gigawatts over the next three years, serving AI training and inference workloads for enterprise and government customers.

Firmus is not a newcomer to large-scale capital raises. The company raised A$830 million in equity across two placements in 2025, backed by Nvidia and Australian investor Ellerston Capital, which established the foundation for Project Southgate. The new US$10 billion debt package represents a categorical shift in scale, moving Firmus from expansion mode into what backers describe as national-scale execution. Blackstone framed the deal as a long-term infrastructure conviction play rather than a short-term technology bet, drawing a parallel to its broader strategy of financing large AI compute and data-centre platforms globally — a strategy that also underpinned its 2024 acquisition of Sydney-based AirTrunk alongside Canada's CPPIB.

The deal carries meaningful near-term significance beyond the capital figure itself. Firmus is preparing for an IPO on the Australian Securities Exchange, with co-founder Oliver Curtis indicating to the Australian Financial Review that a listing is expected in 2026, targeting approximately A$2 billion in proceeds. The company's ability to execute at the scale it has promised — US$70 billion in projected total capital expenditure through 2028 — will be scrutinised by institutional investors ahead of that listing. Critics note that the debt-fuelled model echoes CoreWeave's aggressive US expansion, a comparison that cuts both ways: CoreWeave's revenue growth has been strong, but its post-IPO stock volatility has kept risk questions alive.

For Australia, the Firmus deal is a landmark moment in the country's ambition to be more than a consumer of AI — it signals a bid to become a producer of the infrastructure that powers it. Project Southgate's use of Tasmania's existing hydroelectric grid as a clean energy backbone addresses one of the key constraints facing AI data centres globally: the cost and carbon intensity of power. Blackstone's senior managing director explicitly stated a belief that 'Australia can play a central role' in the AI infrastructure buildout, a framing that carries weight for federal and state policymakers evaluating data sovereignty and digital industrial policy. The forthcoming ASX IPO will be the first major test of whether domestic public markets can support AI infrastructure at this scale, and its outcome will influence how the next cohort of Australian deep-tech companies thinks about capital pathways.

Firmus's $10B Blackstone Loan Positions Australia as a Global AI Compute Hub

While the Firmus deal is Australia-centred, its context is inseparable from the broader APAC consolidation underway. STT GDC — now majority-owned by KKR and Singtel — operates data centres in India as a core part of its 12-market Asia-Pacific and European footprint. As AI-driven demand for colocation and high-density compute accelerates across Indian enterprise and government sectors, the ownership change at STT GDC could influence investment priorities, capacity expansion timelines, and pricing dynamics in the Indian market. India's own data centre buildout — estimated at US$100 billion in capital expenditure — is drawing parallel interest from global infrastructure funds, and the Firmus and STT GDC deals may serve as a benchmark for the scale of financing that Indian AI infrastructure platforms could eventually attract.

India Features in the STT GDC Footprint as APAC's AI Infrastructure Consolidation Deepens

Singapore's digital infrastructure story took on new dimensions the week prior, when KKR and Singtel announced their US$10.9 billion full acquisition of STT GDC — the largest M&A transaction in Singapore in four years. The near-simultaneous arrival of the Firmus financing demonstrates that global capital is treating the two markets as complementary rather than competing nodes in the same regional AI infrastructure network. STT GDC operates across 12 markets including Singapore, India, Southeast Asia, the UK and Europe, with 2.3 GW of design capacity; Firmus targets a 1.6 GW buildout concentrated in Australia. For Singapore-based investors and infrastructure funds, the combined signal is clear: the window for positioning in APAC AI compute infrastructure is open and accelerating rapidly.

Dual $10B Deals in Two Weeks Put Singapore and Australia at the Centre of APAC's AI Infrastructure Race

australia

firmus-technologies

blackstone-tactical-opportunities

blackstone-credit-insurance

coatue-management

ai-factory

nvidia-dsx

cdc-data-centres

nvidia

ellerston-capital

airtrunk

sydney

canada

cppib

australian-securities-exchange

coreweave

Blackstone and Coatue's $10B loan to Firmus is among Australia's largest-ever private debt deals — learn what's at stake for regional AI infrastructure and the coming ASX IPO.

$10B debt deal tests Australia's AI infrastructure ambition

Nvidia-backed Firmus secures one of Australia's largest-ever private debt financings as it races toward an ASX IPO and 1.6 gigawatts of AI capacity.

The scale of the Firmus financing — one of the largest private debt deals in Australian history — signals that institutional capital is no longer treating APAC as a secondary market for AI infrastructure investment. Blackstone, which has deployed more than US$70 billion into data centre assets globally since 2021, chose Australia for a flagship credit transaction, citing energy cost advantages, regulatory flexibility, and proximity to fast-growing regional AI demand. The deal arrives weeks after KKR and Singtel's US$10.9 billion acquisition of STT GDC, underscoring that both Singapore and Australia are now anchoring separate but complementary legs of the region's AI infrastructure buildout.

For APAC investors and policymakers, the paired mega-deals represent a structural shift in how the region is being capitalised. Project Southgate's planned 1.6 GW capacity — built around Nvidia chip architecture and Tasmania's hydroelectric power — positions Australia as a potential sovereign AI compute hub, with ambitions that extend beyond domestic demand into serving hyperscale and AI-native customers globally. The critical test will come when Firmus attempts its ASX IPO later in 2026: whether public markets price the company as a durable infrastructure asset or a heavily leveraged growth bet will set a benchmark for how the region's next wave of AI infrastructure companies access capital.

Blackstone's conviction bet on an Australian AI startup reshapes the regional investment thesis for data centre capital.

Australia's $10B Firmus Deal Signals APAC Is Now Primary AI Infrastructure Territory

Can Australia's Firmus Justify a $10 Billion AI Infrastructure Bet?

Tech Mahindra (NSE: TECHM) announced on 1 May 2026 that it will acquire an 85% stake in Canada-based Avant Techno Solutions — also known as Alluri Technologies — in a cash deal valued at CAD 28 million (approximately USD 21 million). The remaining 15% stake will be acquired by 30 June 2029 under a pre-agreed valuation formula. This is the Pune-headquartered IT services giant's first acquisition since its purchase of Philippines-based BPO firm Orchid Cybertech in 2024, and the deal is expected to close by 31 July 2026. Avant reported annual revenue of CAD 58.6 million in calendar year 2025, up from CAD 53.7 million the year prior.

Founded in 2017, Avant brings deep expertise in payments modernisation and wealth management platforms, spanning real-time payments rails, ISO 20022 migration, wire modernisation, and cloud-based core payment transformation. The acquisition also adds identity and access management capabilities and creates new pathways in open banking, commercial lending, regulatory compliance, and fraud prevention — all critical priorities for North American banks upgrading legacy infrastructure ahead of upcoming regulatory deadlines. CEO Mohit Joshi had publicly flagged in late 2024 that Tech Mahindra wanted BFSI to rise to 25% of total revenue by March 2027, up from roughly 16% at the time. Buying Avant offers a faster route than purely organic capability-building.

The deal is a concise illustration of how India's mid-tier IT services sector is using targeted acquisitions to compete in high-value verticals against larger rivals. Tech Mahindra has historically been more dependent on telecom-linked business than peers such as Infosys or Wipro, making the BFSI pivot strategically urgent. While the CAD 28 million price tag is modest by IT-sector standards, Avant's established client relationships and domain talent in North American financial institutions give Tech Mahindra a credible beachhead in a market where ISO 20022 compliance and real-time payment rail modernisation are generating a multi-year services demand wave.

Australia's 'Big Four' banks — ANZ, CBA, NAB, and Westpac — are in the midst of multi-year core payments modernisation programs, many of which involve Indian IT service providers. A more capable Tech Mahindra in real-time payment rails and ISO 20022 migration is directly relevant to Australian procurement decisions. As Australia's NPP (New Payments Platform) ecosystem matures and banks compete on the speed and resilience of their payment infrastructure, deals like the Avant acquisition signal that Indian IT vendors are moving up the value stack and could displace European and American competitors in future contracting rounds.

Australian Banks Watch as Indian IT Firms Climb the BFSI Value Chain

For investors tracking Tech Mahindra on the NSE, the Avant deal is a strategically logical but execution-dependent bet. CEO Mohit Joshi set a public target of raising BFSI to 25% of revenue by March 2027 — from roughly 16% in late 2024 — and acquisitions are the fastest path to close that gap. Avant's CAD 58.6 million in 2025 revenue is small relative to Tech Mahindra's overall scale, but its talent pool and North American client relationships provide a foundation. Indian analysts will be watching integration timelines closely: the 85%/15% staged structure, with full acquisition by June 2029, gives both parties a long runway but also means full operational control is deferred.

Tech Mahindra's BFSI Ambition Gets a Boost, But Execution Risk Remains

Singapore remains the regional headquarters for many of the global banks that are also Avant's North American target clients. Tech Mahindra already maintains a regional delivery presence in Singapore, and the Avant acquisition's open banking and wealth management capabilities are directly applicable to Singapore's MAS-regulated financial institutions. As MAS continues to push for greater API interoperability and digital banking infrastructure, Indian IT firms with enhanced fintech domain expertise are well-positioned to compete for significant local and regional mandates alongside established players such as Infosys Finacle and TCS BaNCS.

Singapore's Fintech Hub Status Could Draw Expanded Tech Mahindra Attention

tech-mahindra

avant-techno-solutions

alluri-technologies

pune

philippines

orchid-cybertech

iso-20022

real-time-payments-rails

open-banking

infosys

wipro

north-america

What Tech Mahindra's first acquisition since 2024 tells you about Indian IT's race to own North American payments infrastructure before ISO 20022 deadlines hit.

CAD 28M deal signals Tech Mahindra's BFSI pivot

The Indian IT major acquires a specialist fintech to accelerate its push toward a 25% BFSI revenue target by 2027.

Across APAC, the Tech Mahindra-Avant deal will be watched most closely by institutional investors holding Indian IT sector equities and by competing services firms eyeing similar capability gaps. India's IT industry — historically a bulk-labour play for global banks — is increasingly competing on domain IP, and payments modernisation has become one of the clearest battlegrounds. The ISO 20022 migration cycle, which requires banks to overhaul how they encode financial messages across wire transfers and cross-border payments, is generating long-duration contracts that reward firms with deep fintech knowledge over generalist IT suppliers.

For APAC financial services institutions — including Singapore's major banks, Australia's 'Big Four', and India's rapidly digitalising payment ecosystem — the competitive landscape of technology service providers is shifting. A more capable Tech Mahindra in the payments and wealth technology space adds a credible, cost-competitive alternative to legacy Western IT integrators. Indian IT firms that successfully climb the BFSI value chain could reshape vendor selection decisions across the region over the next two to three years.

Tech Mahindra's CAD 28M deal reflects a structural rebalancing underway across India's IT sector as telecom revenues plateau.

Indian IT's BFSI Landgrab: Why Small Acquisitions Like Avant Signal a Bigger Shift

Tech Mahindra Buys Into North American Payments with CAD 28M Avant Deal

Hims & Hers Health announced a definitive agreement to acquire Eucalyptus, Australia's premier digital healthcare platform, for up to $1.15 billion USD. The deal includes $240 million in cash at closing, with deferred payments and earnout provisions extending through 2029. Eucalyptus operates in Australia, the UK, Germany, with expanding operations in Japan and Canada.

The acquisition represents strategic diversification for Hims & Hers amid regulatory challenges in the US, where the company was forced to withdraw its $49 compounded oral semaglutide pill following FDA crackdown and referral to the Department of Justice. Eucalyptus brings an annual revenue run-rate exceeding $450 million and more than 775,000 customers. The Australian company's portfolio includes weight-loss platform Juniper, men's health service Pilot, and fertility brand Kin.

This transaction represents one of the most significant consolidations in telehealth industry history, signaling a decisive shift toward unified global consumer health ecosystems. The acquisition is expected to close mid-2026 following regulatory approvals. For APAC's investment landscape, the deal demonstrates growing appetite for healthcare infrastructure assets, particularly as regional digital health adoption accelerates post-pandemic.

The Eucalyptus cap table includes local funds Blackbird, Airtree, Woolworths VC fund W23, OneVentures, Athletic Ventures, alongside US investor Mary Meeker's BOND Capital. The startup more than tripled its $520 million valuation from April 2023, delivering substantial returns to early Australian backers. Co-founder Tim Doyle is set to bank around $160 million from the deal, becoming SVP of International at the combined entity.

Australia's Largest Telehealth Exit Delivers $1.15B to Local VCs

India maintained strong momentum with 457 deals worth US$13.7 billion in H1 2025, supported by stable regulatory environment and expanding tech opportunities. The Eucalyptus valuation multiple suggests India's largest digital health platforms, with their massive addressable markets and demonstrated unit economics, could command similar premiums from international strategic buyers seeking emerging market exposure.

India's Digital Health Scale Could Drive Mega-Deals

The Eucalyptus premium suggests Singapore's mature digital health platforms could attract similar strategic interest from global acquirers. With Singapore serving as regional headquarters for many international healthcare companies, local telehealth platforms with proven regulatory frameworks and multi-market operations present compelling acquisition targets for US and European consolidators seeking APAC market entry.

Singapore Healthcare VCs Eye Similar Consolidation Plays

hims-and-hers-health

eucalyptus

germany

japan

juniper

pilot

How Hims & Hers' acquisition of Australia's largest telehealth platform reshapes APAC's healthcare investment landscape.

$1.15B Eucalyptus buyout transforms APAC digital health

Hims & Hers' mega-deal marks largest digital health consolidation in APAC history.

Signs emerge that Asia Pacific is producing companies attracting strategic capital at different orders of magnitude once they cross into infrastructure zones. The Eucalyptus acquisition follows broader APAC trends where healthcare platforms achieve premium valuations through proven operational scale and regulatory compliance.

The region is moving according to different logic, shaped by state influence, institutional coordination, fragmented healthcare delivery, and extraordinary demographic pressure. This creates unique opportunities for healthcare consolidation as platforms seek geographic expansion and regulatory arbitrage across diverse APAC markets.

Eucalyptus deal signals shift from venture to strategic acquisitions across region.

APAC Healthcare Infrastructure Attracts Record Strategic Capital

US Telehealth Giant Acquires Australia's Eucalyptus for $1.15 Billion

US telehealth company Hims & Hers Health announced a definitive agreement to acquire Australian digital health leader Eucalyptus for up to $1.15 billion, marking the largest digital health acquisition in Australia's history. The deal, expected to close in mid-2026, will see $240 million paid in cash at closing, with the remainder structured as deferred payments and performance-based earnouts.

Eucalyptus operates multiple consumer healthcare brands including Juniper and Pilot, serving over 775,000 customers across Australia, UK, Germany, Japan and Canada with an annual revenue run-rate exceeding $450 million USD. The acquisition has caught attention across Australia's digital health sector, demonstrating premium valuations for high-growth telehealth platforms, with industry experts noting the deal represents a mid-to-high single-digit historic revenue multiple.

The acquisition enables Hims & Hers' expansion into Australia and Japan while deepening its presence in the UK, Germany and Canada. Following completion, Eucalyptus CEO Tim Doyle will become SVP of International at Hims & Hers, overseeing all international operations. The deal signals significant consolidation in global telehealth and positions Hims & Hers as a leading international consumer health platform.

The $1.15 billion Eucalyptus acquisition represents by far the largest acquisition of a preventative healthcare company in Australia, delivering a sizeable payday for founder Tim Doyle and private equity backers. The deal valuation implies a premium multiple at the upper end of prevailing sector benchmarks.

Eucalyptus was the first Australian telehealth business to receive accreditation from the Australian Council on Healthcare Standards and has published over 20 peer-reviewed studies examining patient outcomes, adherence and safety. The acquisition validates Australia's position as a leading digital health innovation hub.

Australia Sees Largest Digital Health Exit

Recent Singapore investment activity in Australian healthcare includes the $40 million rescue of Seer Medical by Cadwell Industries, Breakthrough Victoria and TrialCap Pte Ltd. Cadwell will integrate Seer's EEG technology into its global neurodiagnostic portfolio, demonstrating continued cross-border healthcare technology interest between the two markets.

Singapore Investors Eye Australian Digital Health

hims-hers

US telehealth giant completes Australia's largest digital health acquisition.

The Eucalyptus acquisition represents one of the most significant consolidations in global telehealth history, turning Hims & Hers into an international powerhouse. This follows broader APAC digital health trends, with strategic deals totalling $2.65 billion in Q1 2026 versus just $244 million in traditional VC funding, highlighting the sector's shift toward infrastructure-led capital.

Industry analysts expect the deal to put Australia's preventative healthcare sector on the radar of both domestic and international buyers. Recent cross-border M&A activity has been relatively small but notably involves overseas acquirers targeting Australian digital health assets, suggesting increased international interest in the region's mature telehealth market.

Major US acquisition signals new era for regional telehealth market.

APAC Digital Health Consolidation Accelerates

Hims Hers Acquires Eucalyptus for $1.15 Billion

Hims & Hers Health (NYSE: HIMS) announced on February 19 its definitive agreement to acquire Eucalyptus, Australia's premier digital healthcare platform, for up to $1.15 billion. The deal, expected to close mid-2026, includes $240 million in cash upfront, with deferred and earnout payments extending through early 2029. Eucalyptus reported over $450 million in annual recurring revenue as of January 2026, having served more than 775,000 customers across Australia, UK, Germany, Japan and Canada.

The transaction represents one of the most significant consolidations in telehealth industry history, signaling a decisive shift toward a unified global consumer health ecosystem. Eucalyptus operates five digital healthcare clinics including women's weight-loss company Juniper, men's health brands Pilot and Compound, reproductive healthcare company Kin, and Software's telehealth services with clinical-grade skincare formulas. The acquisition comes as Hims & Hers faces regulatory volatility in the US following an FDA crackdown on its $49 compounded oral semaglutide pill and subsequent withdrawal.

Upon closing, Hims & Hers will expand into Australia and Japan while deepening presence in UK, Germany and Canada. The company targets over $1 billion in international annual revenue within three years. Eucalyptus CEO Tim Doyle will become SVP of International at Hims & Hers, overseeing global business operations. Regulatory approvals from Australia's Competition and Consumer Commission (ACCC) and Foreign Investment Review Board (FIRB) remain pending.

The AU$1.6 billion acquisition more than triples Eucalyptus's $520 million valuation from its April 2023 funding round, delivering massive returns to local investors including Blackbird, Airtree, Woolworths' W23 fund, OneVentures, and Athletic Ventures. Co-founder and CEO Tim Doyle is set to bank around $160 million from the deal while transitioning to lead Hims & Hers' international operations.

Founded in 2019, Eucalyptus became Australia's first telehealth provider to receive accreditation from the Australian Council on Healthcare Standards, publishing over 20 peer-reviewed studies on care model outcomes. The company operates four demographic-focused brands: Pilot (men's health), Juniper (women's weight loss and menopause), Kin (fertility), and Software (prescription skincare).

Eucalyptus Exit Delivers $1.6 Billion Value to Australian Investors

Indian health tech companies secured significant funding including Plum Benefits ($20.5M employee health insurance) and Even Healthcare ($20M integrated care), reflecting continued investor conviction in the market's affordability-focused innovation. India's digital health market brings intensity of demand and constant pressure on affordability, creating unique innovation dynamics compared to other APAC markets.

India maintained strong private equity momentum with 457 deals worth $13.7 billion in H1 2025, representing 21 percent of regional activity, supported by stable regulatory environment, strong demographics and expanding tech and infrastructure opportunities. China and India are identified as regional bright spots for rapid tech and AI expansion, particularly in healthcare infrastructure development.

India's Health Tech Sector Draws Strategic Investment Interest

Singapore's Temasek Holdings participated in a consortium that invested A$100 million in Australian plastic recycling firm Samsara Eco, while other Singapore entities including Cyan Renewables acquired MMA Offshore for A$1.1 billion. Singapore's Monetary Authority frameworks like the Long-Term Investment Fund (LIF) are opening pathways for private credit expansion across the region.

Southeast Asia markets including Singapore remain highly active in fintech space, with the city-state serving as a key hub for cross-border investment activity. Singapore accounted for 50 percent of Southeast Asian private equity activity despite regional slowdown to $3.6 billion in H1 2025.

Singapore Hub Benefits from Cross-Border Health Tech Flows

compound

software

accc

firb

US telehealth giant targets APAC expansion with Australia's largest digital health platform.

The $1.15 billion transaction consolidates Australia's largest direct-to-consumer telehealth platform into a US-listed global operator. APAC digital health funding reached $2.65 billion in strategic deals versus just $244 million in traditional VC funding during Q1 2026, with Australian companies like Splose ($32M Series A2), Lumonus ($20M), and Omniscient Neurotechnology ($20M) securing significant rounds.

Private equity momentum continues across APAC, with India recording 457 deals worth $13.7 billion in H1 2025, while Southeast Asia activity reached $3.6 billion despite trade tensions shifting production to Vietnam, Indonesia and Thailand. Japan and Australia have seen rapid private equity growth in technology sectors, particularly data centers supporting AI expansion, with J.P. Morgan committing an additional $50 billion to direct lending, some targeting APAC markets.

Arc Brief

Canada

News Coverage

Can Australia's Firmus Justify a $10 Billion AI Infrastructure Bet?

Tech Mahindra Buys Into North American Payments with CAD 28M Avant Deal

Tech Mahindra Buys Into North American Payments with CAD 28M Avant Deal

US Telehealth Giant Acquires Australia's Eucalyptus for $1.15 Billion

Hims Hers Acquires Eucalyptus for $1.15 Billion

Hims & Hers Acquires Australia's Eucalyptus for $1.15 Billion